Literature DB >> 3086503

Dementia in idiopathic Parkinson's disease. Variables associated with its occurrence in 203 patients.

T S Elizan, H Sroka, H Maker, H Smith, M D Yahr.   

Abstract

A series of 203 patients with primary Parkinson's disease treated with L-DOPA, with adequate neurological documentation of mental status at serial intervals during their illness, constitutes the study population. Based on the results of the latest neurological examination, slightly less than one-third (29%) had mental impairment assessed as neurologically significant. Of the eleven clinical variables analysed (Cox regression analysis) for potential influence on the occurrence of an organic mental syndrome, four had a statistically significant effect: (1) the stage of disease at initial neurological examination; (2) the occurrence of acute confusional states; (3) the years of Parkinson's prior to L-DOPA; and (4) the total duration of L-DOPA therapy. The pathogenesis of dementia in this subgroup of Parkinson's disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086503     DOI: 10.1007/bf01249089

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  23 in total

1.  High correlations between number of dopamine cells, dopamine levels and motor performance.

Authors:  C Ranje; U Ungerstedt
Journal:  Brain Res       Date:  1977-09-23       Impact factor: 3.252

2.  Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.

Authors:  F Hefti; E Melamed; R J Wurtman
Journal:  Brain Res       Date:  1980-08-11       Impact factor: 3.252

3.  Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity.

Authors:  K Jellinger; P Riederer
Journal:  Adv Neurol       Date:  1984

4.  A controlled study of dementia in Parkinson's disease.

Authors:  R H Mindham; S W Ahmed; C G Clough
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-11       Impact factor: 10.154

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Present morality in parkinson's disease: the ratio of observed to expected deaths with a method to calculate expected deaths.

Authors:  S G Diamond; C H Markham
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

7.  Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

Authors:  J M Candy; R H Perry; E K Perry; D Irving; G Blessed; A F Fairbairn; B E Tomlinson
Journal:  J Neurol Sci       Date:  1983-05       Impact factor: 3.181

8.  Confusion, dementia and anticholinergics in Parkinson's disease.

Authors:  Y de Smet; M Ruberg; M Serdaru; B Dubois; F Lhermitte; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-12       Impact factor: 10.154

9.  A subcortico-cortical cholinergic system is affected in Parkinson's disease.

Authors:  B Dubois; M Ruberg; F Javoy-Agid; A Ploska; Y Agid
Journal:  Brain Res       Date:  1983-12-12       Impact factor: 3.252

10.  Organic mental syndrome and confusional states in Parkinson's disease. Relationship to computerized tomographic signs of cerebral atrophy.

Authors:  H Sroka; T S Elizan; M D Yahr; A Burger; M R Mendoza
Journal:  Arch Neurol       Date:  1981-06
View more
  7 in total

1.  Selective deficits in cognition and memory in high-functioning parkinsonian patients.

Authors:  E Mohr; J Juncos; C Cox; I Litvan; P Fedio; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-07       Impact factor: 10.154

Review 2.  Diagnosis and treatment of common forms of tremor.

Authors:  Andreas Puschmann; Zbigniew K Wszolek
Journal:  Semin Neurol       Date:  2011-02-14       Impact factor: 3.420

3.  Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

Authors:  B Pillon; B Dubois; G Cusimano; A M Bonnet; F Lhermitte; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

4.  Dementia and cognitive impairment in Parkinson's disease.

Authors:  F Girotti; P Soliveri; F Carella; I Piccolo; P Caffarra; M Musicco; T Caraceni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

5.  Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.

Authors:  Joana Meireles; João Massano
Journal:  Front Neurol       Date:  2012-05-25       Impact factor: 4.003

6.  Mild cognitive impairment in Parkinson's disease: the challenge and the promise.

Authors:  Hubert H Fernandez; Gregory P Crucian; Michael S Okun; Catherine C Price; Dawn Bowers
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

Review 7.  α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis.

Authors:  Laura M Butkovich; Madelyn C Houser; Malú G Tansey
Journal:  Front Neurosci       Date:  2018-09-11       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.